ORAI1 and renal cell carcinoma: While Orai1 controls RCC cell proliferation and migration [133] and TRPC6 up-regulation favors the transition through the G2/M phase [132], the loss of TRPC4 results in a decreased release of the endogenous inhibitor thrombospondin-1, which favors the angiogenic switch [134].